- Home
- OXBR vs OCEA Comparison
OXBR vs OCEA Comparison
Compare OXBR & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXBR
- OCEA
- Stock Information
- Founded
- OXBR 2013
- OCEA 2019
- Country
- OXBR Cayman Islands
- OCEA United States
- Employees
- OXBR N/A
- OCEA N/A
- Industry
- OXBR Property-Casualty Insurers
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- OXBR Finance
- OCEA Health Care
- Exchange
- OXBR Nasdaq
- OCEA Nasdaq
- Market Cap
- OXBR 24.5M
- OCEA 20.5M
- IPO Year
- OXBR 2014
- OCEA N/A
- Fundamental
- Price
- OXBR $4.33
- OCEA $0.54
- Analyst Decision
- OXBR
- OCEA
- Analyst Count
- OXBR 0
- OCEA 0
- Target Price
- OXBR N/A
- OCEA N/A
- AVG Volume (30 Days)
- OXBR 32.9K
- OCEA 617.7K
- Earning Date
- OXBR 11-13-2024
- OCEA 01-13-2025
- Dividend Yield
- OXBR N/A
- OCEA N/A
- EPS Growth
- OXBR N/A
- OCEA N/A
- EPS
- OXBR N/A
- OCEA N/A
- Revenue
- OXBR N/A
- OCEA N/A
- Revenue This Year
- OXBR N/A
- OCEA N/A
- Revenue Next Year
- OXBR N/A
- OCEA N/A
- P/E Ratio
- OXBR N/A
- OCEA N/A
- Revenue Growth
- OXBR N/A
- OCEA N/A
- 52 Week Low
- OXBR $0.87
- OCEA $0.46
- 52 Week High
- OXBR $4.96
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- OXBR 60.87
- OCEA 40.01
- Support Level
- OXBR $3.63
- OCEA $0.53
- Resistance Level
- OXBR $4.11
- OCEA $0.70
- Average True Range (ATR)
- OXBR 0.43
- OCEA 0.08
- MACD
- OXBR -0.02
- OCEA -0.00
- Stochastic Oscillator
- OXBR 52.26
- OCEA 4.31
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.